title: Uses of epoetin for anemia in oncology.
authors.forename: J
authors.initials: J
authors.lastname: Seidenfeld
authors.forename: N
authors.initials: N
authors.lastname: Aronson
authors.forename: M
authors.initials: M
authors.lastname: Piper
authors.forename: C R
authors.initials: CR
authors.lastname: Flamm
authors.forename: V
authors.initials: V
authors.lastname: Hasselblad
authors.forename: K M
authors.initials: KM
authors.lastname: Ziegler
mesh_terms: D000743:Anemia, Hemolytic / Q000188:drug therapy* / Q000209:etiology*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016465:Bone Marrow Purging / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D004921:Erythropoietin